Effects of Kinesio Tape on Delayed Onset Muscle Soreness

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine the effect of Kinesio tape on delayed onset muscle soreness of the biceps muscle of your arm following strenuous exercise of the bicep muscle.

Clinical Trial Description

Participants will complete 4 testing sessions that will be held on 4 separate days (Baseline, Eccentric Exercise day, 48 hours post exercise, and 72 hours post exercise). All sessions will take place in the National Institute of Fitness and Sport, where the Department of Kinesiology laboratories are located. During the first session (Baseline), the purpose and procedures of the research will be explained by the investigator, co-investigator, or a research assistant in more detail. Participants will read and sign the informed consent form and then undergo an exclusion/inclusion criteria assessment which includes the Physical Activity Readiness Questionnaire (PAR-Q), and brief questionnaire. All study personnel/staff obtaining informed consent will be trained in the responsible conduct of research. All participants will be asked if they have a known allergy to Kinesio Tape (KT) or if they have sensitive skin. Those with sensitive skin will be administered an allergy test. After screening and enrollment, participants will complete baseline assessments of muscle pain and function, pain sensitivity, and psychological risk factors (See outcome measures). During Session 2, strength of the non-dominant bicep will be measured first. Participants will then perform an eccentric exercise protocol designed to induce delayed onset muscle soreness (DOMS) on the non-dominant arm. Strength of the non-dominant bicep will be measured immediately post the eccentric exercise protocol. At the end of this session, subjects will be randomly assigned to one of two intervention groups (experimental KT group, placebo KT group) or a control group (i.e., no intervention performed). The experimental group will receive KT with proper technique and tension (10-20%), while the placebo group will receive KT without technique and tension. Sessions 3 and 4 will occur approximately 48 and 72 hours post Session 2, respectively. All the outcome variables will be measured during these sessions. For participants in the KT groups, the tape will be removed at the end of session 4, as described below. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04128670
Study type	Interventional
Source	Indiana University
Contact	Kelly M Naugle, PhD
Phone	3172740601
Email	kmnaugle@iupui.edu
Status	Recruiting
Phase	N/A
Start date	January 30, 2020
Completion date	January 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02602353` - Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)	Phase 2
Completed	`NCT02339129` - Dosing Interval Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness	Phase 2
Completed	`NCT03876080` - Dry Needling in Subjects With Delayed Onset Muscle Soreness	N/A
Completed	`NCT02087748` - An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS	Phase 4
Recruiting	`NCT03619928` - Comparison of Dry Needle and Massotherapy on Tolerance Effort and Soreness	N/A
Completed	`NCT02322489` - Efficacy of Microcurrent Therapy After Eccentric Exercise	N/A
Completed	`NCT02324985` - Phase II Study of AP0302 5% Versus a Vehicle Comparator	Phase 2
Completed	`NCT04012203` - Multivariable Recovery After Exercise-induced Muscle Pain in the Forearm Muscles
Completed	`NCT02113566` - A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness	Phase 4
Completed	`NCT05326893` - The Preventive Effects of Neurodynamic Mobilisation	N/A
Completed	`NCT02018211` - Neuromuscular Electrical Stimulation Via the Peroneal Nerve Reduces Muscle Soreness Following Intermittent Exercise	N/A
Completed	`NCT04755608` - The Effect of Low-Intensity Resistance Exercise Training	N/A
Completed	`NCT05026944` - Effects of Percussive Massage Treatment With Theragun on Post Exercise Delayed Onset Muscle Soreness	N/A
Active, not recruiting	`NCT06076356` - Effects of Foam Roller Versus KT Tape on Delayed Onset Muscle Soreness	N/A
Completed	`NCT02157675` - Effects of a Polyherbal Supplement on the Signs and Symptoms of Delayed Onset Muscle Soreness	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.